drugset / Trial / NCT00418860
The Optimal Duration of Dual Antiplatelet Therapy After Implantation of Endeavor Stent
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study to determine whether the dual antiplatelet therapy (aspirin and clopidogrel) for 3 months after coronary implantation of zotarolimus-eluting stent is safe in terms of death, myocardial infarction, or stent thrombosis.
Timeline
- Start
- 2006-09
- Primary completion
- 2008-04
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 100 mg | — |
| Subject | Clopidogrel | Small molecule | 75 mg | — |